brolucizumab-dbll | B761125 | NOVARTIS PHARMS CORP
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Oct. 7, 2031 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12371481(method of use) · relevance 90/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
46 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.